Evidence map›Paper›PMID 41140136›Full record

ArticleTurkish journal of ophthalmology2025

Preferred Retinal Locus in Juvenile Macular Dystrophy.

Murat Erbezci, Zühal Özen Tunay, Taylan Öztürk

Abstract read
In one paragraph

Article in Turkish journal of ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Reply.Turkish journal of ophthalmology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Murat ErbezciPrivate Practice, İzmir, Türkiye.ORCID 0000-0003-2163-2157
Zühal Özen TunayTOBB University of Economics and Technology Faculty of Medicine, Department of Ophthalmology, Ankara, Türkiye.ORCID 0000-0002-2133-8970
Taylan ÖztürkTınaztepe University Faculty of Medicine, Department of Ophthalmology, İzmir, Türkiye.ORCID 0000-0001-6633-0553

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To evaluate foveal lesion and preferred retinal locus (PRL) locations and their effects on visual acuity in juvenile macular dystrophy (JMD) patients. Materials and Methods: In this retrospective study, 14 JMD patients (28 eyes) with bilateral central vision loss were examined using scanning laser ophthalmoscope/optical coherence tomography. Best-corrected visual acuity (BCVA), dimensions and location of the macular lesion, PRL location, and PRL stability were evaluated. Results: Mean BCVA was 0.84±0.17 logarithm of the minimum angle of resolution. PRL was superiorly located in 64.3% of eyes and nasally located in 35.7%. PRL location was significantly associated with patient age (r=0.541, p=0.002); nasally located PRLs were more common in younger patients (mean age 15.1±2.8 years) while superiorly located PRLs were more common in older patients (mean age 22.4±6.9 years). Superiorly located PRLs were significantly closer to the fovea than nasally located PRLs (p=0.014). Visual acuity worsened as lesion size increased and PRL-fovea distance increased. PRL-fovea distance was longer in younger patients and positively correlated with lesion dimensions and PRL-lesion distance. Conclusion: In JMD patients, PRLs are predominantly located superiorly or nasally. In younger patients, PRLs are typically located nasally and farther from the fovea, with poorer visual acuity compared to older patients. Cortical adaptation mechanisms may play a role in changing PRL location with age. Understanding PRL characteristics in JMD is crucial for developing effective low-vision rehabilitation strategies.

Indexed as

Fovea CentralisMacular DegenerationTomography, Optical CoherenceVisual AcuityAdolescentAdultChildFemaleFluorescein AngiographyFollow-Up StudiesHumansMaleOphthalmoscopyRetrospective StudiesYoung Adultcentral scotomajuvenile macular degenerationlow visionMacula

Identifiers

PMID41140136
PMCPMC12559831

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.